Literature DB >> 15825425

Iododeoxyuridine and herpesviral encephalitis: lack of inhibitory action against low-grade viral replication.

G Plummer, A P Ingerson.   

Abstract

Equine herpesvirus 1 replicated in the brains of 2-week-old mice but did not produce fatal encephalitis; it thus simulated the majority of cases of herpes simplex encephalitis in man. This replication was not inhibited by iododeoxyuridine, although in tissue cultures the equine and human viruses were equally susceptible. The continued use of iododeoxyuridine for human encephalitis should be seriously questioned.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 15825425      PMCID: PMC429034          DOI: 10.1128/AAC.5.6.672

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Herpesvirus hominis infection in newborn mice. I. An experimental model and therapy with iododeoxyuridine.

Authors:  E R Kern; J C Overall; L A Glasgow
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

2.  Neurovirulence of equine herpesvirus type I in mice of different ages.

Authors:  G Plummer; P L Coleman; P H Cleveland; D Henson
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

3.  Idoxuridine in herpes simplex virus (type 1) encephalitis. Experience with 29 cases in Michigan, 1966 to 1971.

Authors:  D C Nolan; C B Lauter; A M Lerner
Journal:  Ann Intern Med       Date:  1973-02       Impact factor: 25.391

4.  In vivo antiviral properties of biologically active compounds. II. Studies with influenza and vaccinia viruses.

Authors:  R W Sidwell; G J Dixon; S M Sellers; F M Schabel
Journal:  Appl Microbiol       Date:  1968-02
  4 in total
  3 in total

1.  Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine.

Authors:  E R Kern; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

2.  Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.

Authors:  E de Clercq; Z X Zhang; I S Sim
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  Experimental herpes simplex virus type 1 encephalitis: treatment with 5-trifluoromethyl-2'-deoxyuridine.

Authors:  D W Clough; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.